ÉTUDE PRODIGE 106-FFCD-DIAMOND - En cours de lancement

Title

Early adaptation of strategy by De-escalation or Intensification therapy According to circulating tuMOr DNA variation after 3 cycles of Doublet chemotherapy plus bevacizumab in metastatic non-resectable colorectal cancer (DIAMOND study)

Coordonateur

FIORE di F.

Co-Coordonateur

Promoteur

CHU ROUEN

Localisation

Cancer Colorectal Métastatique

Phase

IIR

NOMBRE DE PATIENTS ATTENDU

470

Statut

En cours de lancement

CONTACT

prodige106.diamond@ffcd.fr